MILLER VALUE PARTNERS LLC 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-10-12 1:40 pm Sale | 2021-09-30 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 25,253 1.730% | -83,108![]() (-76.70%) | Filing |
2021-02-16 10:05 am Sale | 2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 108,361 7.450% | -1,787![]() (-1.62%) | Filing |
2020-02-14 2:38 pm Purchase | 2019-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT | MILLER VALUE PARTNERS LLC | 110,148 8.940% | 48,383![]() (+78.33%) | Filing |